Implantpro - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 236,141 | 430,237 | 533,638 | 1,014,850 | 1,787,374 | 1,805,731 | 1,710,114 | 1,984,821 |
| Profit before tax | 61,431 | 134,710 | 166,248 | 301,587 | 572,865 | 559,005 | 436,563 | 494,855 |
| Net profit | 52,165 | 114,164 | 140,015 | 255,850 | 485,497 | 474,087 | 370,372 | 414,477 |
| Equity | 84,478 | 198,642 | 276,775 | 465,566 | 909,887 | 1,213,921 | 1,377,995 | 1,582,729 |
| Liabilities | 79,814 | 106,926 | 163,371 | 127,995 | 169,921 | 80,723 | 53,409 | 83,092 |
| Non-current assets | 390 | 19,023 | 23,413 | 24,349 | 22,704 | 18,680 | 13,276 | 10,512 |
| Current assets | 163,876 | 286,472 | 416,655 | 568,319 | 1,055,429 | 1,271,464 | 1,414,461 | 1,652,644 |
| Total assets | 164,266 | 305,495 | 440,068 | 592,668 | 1,078,133 | 1,290,144 | 1,427,737 | 1,663,156 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 515,671 | 516,455 | 474,369 |
| Social insurance contributions | - | - | - | - | - | 50,757 | 54,859 | 60,321 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +706.8% | +82.2% | +24.0% | +90.2% | +76.1% | +1.0% | -5.3% | +16.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 31.8% | 37.4% | 31.8% | 43.2% | 45.0% | 36.7% | 25.9% | 24.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 61.7% | 57.5% | 50.6% | 55.0% | 53.4% | 39.1% | 26.9% | 26.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 22.1% | 26.5% | 26.2% | 25.2% | 27.2% | 26.3% | 21.7% | 20.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 26.0% | 31.3% | 31.2% | 29.7% | 32.1% | 31.0% | 25.5% | 24.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.5 | 0.6 | 0.3 | 0.2 | 0.1 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 118,071 | 215,119 | 152,468 | 206,409 | 310,848 | 296,834 | 250,262 | 270,659 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Implantpro - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-16 | 2025-05-22 | 4804.40 |
| 2024-03-18 | 2024-03-18 | 5180.23 |
| 2024-01-18 | 2024-02-13 | 0.01 |
| 2022-09-16 | 2022-09-25 | 163.86 |
| 2022-07-18 | 2022-07-24 | 3784.81 |
Implantpro - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-19 | 2024-12-19 | 11787.83 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Implantpro, UAB (code 304640036) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €1.98M and net profit of €414.5K, with a profit margin of 20.9%. Revenue increased by 16.1% year on year, and over the 2023–2025 period sales moved from €1.81M to €1.71M and then to €1.98M, showing a recovery and renewed growth after the 2024 dip. Net profit followed a similar pattern, easing from €474.1K in 2023 to €370.4K in 2024 before improving to €414.5K in 2025. The balance sheet remained solid, with total assets of €1.66M, equity of €1.58M and liabilities of €83.1K in 2025. The equity ratio was 95.2% and debt to equity stood at 0.05, indicating very limited leverage. Asset turnover was 1.19x, while revenue per employee reached €283.5K and profit per employee €59.2K.